Dentists in Eielson Afb, AK Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. Glen William Myers, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2630 Central Ave, Eielson Afb, AK 99702 Phone: 907-377-6767 |
Dr. Matthew Gray Corbin, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2630 Central Ave, Eielson Afb, AK 99702 Phone: 907-377-6767 |
Dr. Tann Samuel Jones, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2406 Mukluk Loop Apt B, Eielson Afb, AK 99702 Phone: 435-764-8057 |
 Dr. Holly Vokoun Ellenberger, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2630 Central Ave, Eielson Afb, AK 99702 Phone: 907-377-6744 |
Alexandra Rene Giett, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2630 Central Ave # 3349, Eielson Afb, AK 99702 Phone: 907-377-6767 |
John Frederick Hamilton Jr., DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 3349 Central Ave, 354 Mdos/sgod Ste 1m07, Eielson Afb, AK 99702 Phone: 907-377-6582 |
News Archive
Common pain and anti-inflammation drugs may slow cancer growth
Scientists from the Florida campus of The Scripps Research Institute have found that one of the most widely prescribed pain and anti-inflammation drugs slows the growth rate of a specific kind of cancer in animal models and suggests the medication could have the same effect on other types of tumors.
Greater medical care needed for older adults with untreated sleep apnea
Obstructive sleep apnea is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death.
SciClone initiates phase 2b study of SCV-O7 for oral mucositis
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
New research reports evaluating nephrology market in Europe released
BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports, TreatmentTrends: Renal Anemia and TreatmentTrends: Bone and Mineral Metabolism, are derived from the responses of over 200 European nephrologists polled in May and June, 2010 regarding their approach to managing renal anemia and bone and mineral disturbances in their dialysis and chronic kidney disease patients.
› Verified 7 days ago
Dentists
Pharmacists
Clinical Social Workers
Psychologists
Counselors